Showing results (81-90 of 362) with videos related to
Sort By:
Pageof 37
Clinical Therapeutics|December 24, 2017
Exposure- and Dose-response Analyses in Dose Selection and Labeling of FDA-approved BiologicsKen Ogasawara, Christopher D Breder, Dora H Lin, et al.Journal of General Internal Medicine|July 29, 2008
The impact of the Medicare Part D prescription benefit on generic drug useJames X Zhang, Wesley Yin, Shawn X Sun, et al.JAMA|March 22, 2017
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013J Bradley Layton, Yoonsang Kim, G Caleb Alexander, et al.JAMA|July 9, 2026
Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United StatesJoseph F Levy, G Caleb Alexander, Boris Vabson, et al.Archives of Internal Medicine|May 22, 2002
The "Hassle Factor": what motivates physicians to manipulate reimbursement rules?Rachel M Werner, G Caleb Alexander, Angela Fagerlin, et al.Journal of the National Medical Association|January 31, 2008
A qualitative study of physicians' engagement in reducing healthcare disparitiesSusanne K Vanderbilt, Matthew K Wynia, Margaret Gadon, et al.Health Affairs (Project Hope)|March 7, 2007
General internists' views on pay-for-performance and public reporting of quality scores: a national surveyLawrence P Casalino, G Caleb Alexander, Lei Jin, et al.Pharmacotherapy|June 6, 2022
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary reviewThomas J Moore, Abdallah Alami, G Caleb Alexander, et al.Health Affairs (Project Hope)|March 4, 2015
Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to accessLainie Rutkow, Lydia Turner, Eleanor Lucas, et al.Journal of General Internal Medicine|August 7, 2008
National prevalence of lifestyle counseling or referral among African-Americans and whites with diabetesMonica E Peek, Hui Tang, G Caleb Alexander, et al.Pageof 37